CSS LLC’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,000
Closed -$30.9K 1021
2023
Q2
$30.9K Buy
+14,000
New +$29K ﹤0.01% 803
2014
Q4
Sell
-1,702
Closed -$41K 858
2014
Q3
$41K Hold
1,702
﹤0.01% 733
2014
Q2
$41K Buy
+1,702
New +$55.5K ﹤0.01% 720

CSS LLC's PRTK Position: Q3 2023 in Review

CSS LLC sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 14,000 shares — an estimated $30.9K sold.

CSS LLC first reported a position in PRTK in Q2 2014 and held it in 3 quarters. The position peaked at $41K in Q3 2014. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

  • CSS LLC reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • CSS LLC sold 14,000 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $30.9K.
  • CSS LLC first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2014 and held it in 3 quarters.
  • CSS LLC's Paratek Pharmaceuticals, Inc. position peaked at $41K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on CSS LLC's 13F filing for Q3 2023, filed 14 Nov 2023.